Sadaf Javaid
Child & Adolescent Psychiatry · Shreveport, LANPI 1487880407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,145, 5.9 times the $195 reported in 2019. Among child & adolescent psychiatry clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$867
- Corium, LLC$568
- Supernus Pharmaceuticals, Inc.$485
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$339
- Ironshore Pharmaceuticals Inc.$280
- Axsome Therapeutics, Inc.$276
- plus $1K from 11 others
What the payments were for
- Food & beverage$3,861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$129
How this compares
$3,861 in reported general payments places this provider in the 90th percentile of 70 child & adolescent psychiatry providers in Louisiana.
See all child & adolescent psychiatry providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 15 | $144 |
| Fluoxetine Hcl | 12 | $5 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Shreveport
- Manish SaranShreveport$11K
- Swathi ParvataneniShreveport$4K
- Katherine SmithShreveport$3K
- Keerthiga RaveendranShreveport$3K
- Hannah ScottShreveport$162
- John WagnerShreveport$153
- McLeod GwynetteShreveport$139
- Jason WuttkeNew Orleans$11K
- Nicholas LavinLafayette$6K
- Mark SandsMetairie$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.